aTyr Pharma
LIFE
$1.90
Share price
2.70%
Change (1 day)
-9.95%
Change (1 year)
Categories
aTyr Pharma (LIFE) - Cash on Hand
Cash on Hand as of March 2024 : $84.49 M
According to aTyr Pharma's latest financial reports the company has $84.49 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
aTyr Pharma - Cash on Hand chart (from 2014 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $98.16 M | 48.41% |
| 2022-12-31 | $66.14 M | -38.7% |
| 2021-12-31 | $0.10 B | 240.53% |
| 2020-12-31 | $31.68 M | 1.75% |
| 2019-12-31 | $31.14 M | -37.14% |
| 2018-12-31 | $49.54 M | -41.79% |
| 2017-12-31 | $85.11 M | 17.98% |
| 2016-12-31 | $72.14 M | -24.48% |
| 2015-12-31 | $95.53 M | 502.63% |
| 2014-12-31 | $15.85 M | -56.52% |
| 2013-12-31 | $36.45 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Vertex Pharmaceuticals VRTX | $10.17 B | 11,937.61% | 🇺🇸 USA |
 Veracyte VCYT | $0.20 B | 147.57% | 🇺🇸 USA |